Mad Money with Jim Cramer – Jan 12, 2026 (Mon): Key Points & Links｜要点・関連リンク

[Jun Kurema (暮眞★潤)]

This page lists the main topics and stocks discussed on Mad Money with Jim Cramer aired on January 12 2026, with links to CNBC articles, videos, and English transcripts.

2026年1月12日放送の 「Mad Money with Jim Cramer」 で取り上げられた主な話題・銘柄を、CNBCの記事・動画・英文トランスクリプトへのリンクとともに一覧化しています。

 

(1) Jerome Powell shouldn’t be prosecuted, Jim Cramer says (https://www.cnbc.com/2026/01/12/jerome-powell-doj-jim-cramer.html)

• As the Justice Department investigates Federal Reserve Chief Jerome Powell, CNBC’s Jim Cramer on Monday explained why he thinks Powell should not be prosecuted.
• He also said Wall Street’s doesn’t think the Justice Department will actually press charges.
• “You don’t want to end up with a situation where the Fed Chief actually gets prosecuted, because that would end the very idea of Fed independence or Justice Department independence, for that matter,” he said.

 

(2) Executive Interview: Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs (https://www.cnbc.com/2026/01/12/novo-nordisk-ceo-glp-1-pill-access.html)

• In a Monday interview with CNBC’s Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the pharmaceutical giant’s new pill format of its weight loss drug will allow more people to use the medicine.
• GLP-1 drugs had previously only been available as injectables.
• “We are seeing, actually, that the pill is able to expand the market for a large group of people that have been waiting,” Doustdar said. “Predominantly, I would say the major barrier has been the taboo.”

Ticker: NVO

 

(3) [No Video Clip for non-Club members] Executive Interview: Medtronic CEO Geoff Martha goes one-on-one with Jim Cramer (https://www.cnbc.com/video/2026/01/12/medtronic-ceo-geoff-martha-goes-one-on-one-with-jim-cramer.html)

Medtronic Chairman and CEO Geoff Martha joins ‘Mad Money’ host Jim Cramer at the JPMorgan Health Care Conference to talk its recent growth and opportunities ahead.

Ticker: MDT

 

(4) [No Video Clip for non-Club members] Executive Interview: Pfizer is a powerhouse – we will be able to play a significant role in weight loss, says CEO Albert Bourla (https://www.cnbc.com/video/2026/01/12/pfizer-is-a-powerhouse—we-will-be-able-to-play-a-significant-role-in-weight-loss-says-ceo-albert-bourla.html)

Pfizer Chairman and CEO Albert Bourla joins ‘Mad Money’ host Jim Cramer at the JPMorgan Health Care Conference to talk its weight loss offerings, its guidance for the upcoming year, and more.

Ticker: PFE

 

(5) Cramer’s Lightning Round: Sony is a buy (https://www.cnbc.com/2026/01/12/cramers-lightning-round-sony-is-a-buy.html)

• CubeSmart: “Not enough growth, and there are others that are better.”
• Sony: “I’m going to say it is a buy. The stock is under valued.”

Ticker: CUBE, SONY

 

(6)[No Video Clip for non-Club members]Executive Interview: Bausch + Lomb CEO Brent Saunders sits down with Jim Cramer (https://www.cnbc.com/video/2026/01/12/bausch-lomb-ceo-brent-saunders-sits-down-with-jim-cramer.html)

Brent Saunders, Bausch + Lomb Chairman and CEO, joins ‘Mad Money’ host Jim Cramer to talk investing in TikTok ads, its product pipeline, industry consolidation, and more.

Ticker: BLCO

 

Other Stocks Discussed (calls with audience)/ この日の放送で取り上げられたその他の銘柄（視聴者からの電話): Shopify (SHOP) [buy; goes higher]

 

Ref: Links related to this episode /参考: この日の放送に関するその他のサイトへのリンク:

• Podcast at Spotify (Sound /音声）
• InternetArchive（Video & Texts per minute /1分毎のビデオ＆テキスト）

 

Disclaimer/ 免責事項

****************************

Previous Episode/ 前回のエピソード

Next Episode / 次回のエピソード

 

[Author]

Posts